WITHDRAWN: LINC00342 promotes thyroid carcinoma progression by targeting miR-384/CHMP5 pathway-Reference-Cited by-全球学者库

WITHDRAWN: LINC00342 promotes thyroid carcinoma progression by targeting miR-384/CHMP5 pathway

Published:2021-07 Issue: Volume:223 Page:153272
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Lv Dan,Tan Lin,Ma Hongying,Zhang Yun,Lin Jun,Yu Yiming,Chen Zhongbo,Zhang Qiaoli,Ding Qunli,Deng Zaichun

Funder

Natural Science Foundation of Zhejiang

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference35 articles.

1. The treatment of thyroid carcinoma with radioactive iodine;Beierwaltes;Seminars in nuclear medicine,1978

2. MicroRNA-146b: A Novel Biomarker and Therapeutic Target for Human Papillary Thyroid Cancer;Chou;International journal of molecular sciences,2017

3. Long noncoding RNA PVT1 enhances the viability and invasion of papillary thyroid carcinoma cells by functioning as ceRNA of microRNA-30a through mediating expression of insulin like growth factor 1 receptor;Feng;Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,2018

4. MicroRNAs in thyroid development, function and tumorigenesis;Fuziwara;Mol Cell Endocrinol,2017

5. MiR-384 represses tumorigenesis by regulating CDK6 and predicts prognosis of clear cell renal cell carcinoma;Guo;Journal of B.U.ON. : official journal of the Balkan Union of Oncology,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. WITHDRAWN: LINC00342 promotes thyroid carcinoma progression by targeting miR-384/CHMP5 pathway;Pathology - Research and Practice;2021-07